Colin H. is a seasoned drug development leader with over 36 years of experience in life sciences, focusing on early and late-stage clinical development for both small and large molecules. They have successfully led multiple drug approvals and have held significant leadership roles in various therapeutic areas at prominent companies including Eli Lilly & Co., Procter & Gamble Pharmaceuticals, and Eiger BioPharmaceuticals. Currently, Colin serves as SVP of Clinical Development at Juvena Therapeutics and is the President & CEO of Ridgeway Therapeutics. Colin's educational background includes a degree in Medical Biochemistry from the University of Surrey and an ongoing Bachelor of Medicine, Bachelor of Surgery (MBBS) from the University of London.
Location
Menlo Park, United States
This person is not in any teams
This person is not in any offices